Scribd Logo
Upload

Welcome to Scribd!

  • 94 views

    S Mechanism of Action: Intercalates With DNA, Directly Affecting Transcription and Translation

    Uploaded by

    BigBoosting
    Daunorubicin is an anthracycline antibiotic used to treat acute leukemias. It works by intercalating with DNA and inhibiting DNA re-ligation by topoisomerase II, leading to DNA damage and apoptosis. It is administered intravenously and rapidly distributes to tissues except the brain. It is metabolized and excreted in the bile, with a half-life of around 30 hours. High doses can cause cardiac toxicity, bone marrow suppression, and other side effects due to generation of reactive oxygen species. It is commonly used in combination with cytarabine for acute myelogenous leukemia.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOC, PDF, TXT or read online from Scribd

    S Mechanism of Action: Intercalates With DNA, Directly Affecting Transcription and Translation

    Uploaded by

    BigBoosting
    94 views2 pages
    Daunorubicin is an anthracycline antibiotic used to treat acute leukemias. It works by intercalating with DNA and inhibiting DNA re-ligation by topoisomerase II, leading to DNA damage and apoptosis. It is administered intravenously and rapidly distributes to tissues except the brain. It is metabolized and excreted in the bile, with a half-life of around 30 hours. High doses can cause cardiac toxicity, bone marrow suppression, and other side effects due to generation of reactive oxygen species. It is commonly used in combination with cytarabine for acute myelogenous leukemia.

    Original Description:

    Daunorubicin

    Original Title

    Daunorubicin

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    DOC, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Daunorubicin is an anthracycline antibiotic used to treat acute leukemias. It works by intercalating with DNA and inhibiting DNA re-ligation by topoisomerase II, leading to DNA damage and apoptosis. It is administered intravenously and rapidly distributes to tissues except the brain. It is metabolized and excreted in the bile, with a half-life of around 30 hours. High doses can cause cardiac toxicity, bone marrow suppression, and other side effects due to generation of reactive oxygen species. It is commonly used in combination with cytarabine for acute myelogenous leukemia.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOC, PDF, TXT or read online from Scribd
    Download as doc, pdf, or txt
    94 views2 pages

    S Mechanism of Action: Intercalates With DNA, Directly Affecting Transcription and Translation

    Uploaded by

    BigBoosting
    Daunorubicin is an anthracycline antibiotic used to treat acute leukemias. It works by intercalating with DNA and inhibiting DNA re-ligation by topoisomerase II, leading to DNA damage and apoptosis. It is administered intravenously and rapidly distributes to tissues except the brain. It is metabolized and excreted in the bile, with a half-life of around 30 hours. High doses can cause cardiac toxicity, bone marrow suppression, and other side effects due to generation of reactive oxygen species. It is commonly used in combination with cytarabine for acute myelogenous leukemia.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOC, PDF, TXT or read online from Scribd
    Download as doc, pdf, or txt
    of 2

    DRUG STUDY AND INFORMATION FORM Generic Name: Daunorubicin Trade Name: Daunomycin, Rubidomycin, Cerubidine Drug Class:

    Anthracyclines and Anthracenediones (Antibiotics) Structure/Chemistry: Possess a tetracycline ring structure attached to a sugar, daunosamine, with quinone and hydroquinone moieties on adjacent rings that permit the gain and loss of electrons.

    Pharmacodynamics

    Mechanism of Action: Intercalates with DNA, directly affecting transcription and translation. Forms a tripartite complex with topoisomerase II and DNA and prevents re-ligation of doublestranded breaks made by topoisomerase II which leads to apoptosis. Also generates free radicals by formation of semiquinone radical intermediates from quinone groups that react with O2 to produce superoxide anion radicals (increased radical production in combination with iron).

    Pharmacologic Effects: DNA damage through inhibition of re-ligation by topoisomerase II. Apoptosis due to p53 and caspases.

    Drug Resistance or Tolerance: Overexpression of transcription-linked DNA repair, multidrug resistance, MRP (Multidrug Resistance-associated Proteins) transporter family, breast cancer resistance protein, increased glutathione peroxidase activity, decreased activity or mutation of topoisomerase II, and enhanced ability to repair DNA strand breaks.

    Pharmacokinetics

    Absorption: IV administration of 25-45 mg/m2/day for 3 days.

    Distribution: Rapidly enters heart, kidneys, lungs, liver, and spleen. Does not cross bloodbrain barrier.

    Elimination: t1/2 of 30 hours. Eliminated by metabolic conversion to a variety of aglycones and other inactive products. Biliary excretion. Delayed in presence of hepatic dysfunction.

    Metabolism: All anthracyclines are converted to an active alcohol intermediate.

    Adverse Side Effects/Toxicity: High doses associated with cardiac toxicity subsequent to free radical generation (protection against via iron chelators [Dexrazoxane]), bone marrow suppression, stomatitis, alopecia, GI disturbances, and rash. Avoid extravasation.

    Drug Interactions:

    Therapeutic uses: Acute leukemias. Also used for AML (Acute myelogenous leukemia) in combination with Ara-C.

    Miscellaneous: Derived from Streptomyces peucetius var. caesius. May impart red color to urine.

    You might also like